ML-299

ML-299 is a dual inhibitor of phospholipase D1 (PLD1) and PLD2 (IC50s = 6 and 20 nM, respectively). It is selective for PLD1 and PLD2 over a panel of 65 receptors but also inhibits human-ether-a-go-go (hERG), also known as Kv11.1, as well as kappa- and µ-opioid receptors at 10 µM. ML-299 (1 and 10 µM) decreases invasive migration of U87MG glioblastoma cells.Formal Name: 4-bromo-N-[(1S)-2-[1-(3-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-8-yl]-1-methylethyl]-benzamide. CAS Number: 1426916-00-8. Synonyms: CID-56593087. Molecular Formula: C23H26BrFN4O2. Formula Weight: 489.4. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 30 mg/ml, DMF:PBS (pH 7.2) (1:20): 0.5 mg/ml, DMSO: 25 mg/ml, Ethanol: 1 mg/ml. lambdamax: 247 nm. SMILES: BrC1=CC=C(C(N[C@@H](C)CN2CCC3(C(NCN3C4=CC(F)=CC=C4)=O)CC2)=O)C=C1. InChi Code: InChI=1S/C23H26BrFN4O2/c1-16(27-21(30)17-5-7-18(24)8-6-17)14-28-11-9-23(10-12-28)22(31)26-15-29(23)20-4-2-3-19(25)13-20/h2-8,13,16H,9-12,14-15H2,1H3,(H,26,31)(H,27,30)/t16-/m0/s1. InChi Key: RFKXAYJUFUZBMA-INIZCTEOSA-N.